Revolutionizing Healthcare The AI-Powered Future of Drug Discovery 2022-29

Umesh kokane

Revolutionizing Healthcare The AI-Powered Future of Drug Discovery 2022-29

AI in Drug Discovery Market:

AI in Drug Discovery Market size was valued at USD 1163.16 Mn. in 2022 and the total market revenue is expected to grow by 29.5% from 2023 to 2029, reaching nearly USD 7104.46 Mn.

AI in Drug Discovery Market Report Overview:

The use of the Artificial Intelligence has been increasing in various sectors of Pharmaceutical Industry. AI models are used to determine relationship between the structural properties of chemical compounds and biological toxicity. AI is impacting drug discovery in new and previously unimaginable ways.Investors have largerly gravitated toward the hype throwing an un-precedented amount of funding toward Artificial Intelligence in Drug Discovery.

The research is based on forecasts from leading organizations and Nanozymes market statistics. It also includes sales growth figures, competitive landscape for the forecast period, and valuations of individual companies at the global, regional, and local levels.

AI in Drug Discovery Market Dynamics:

Novartis and Microsoft signed a multi-year strategic agreement in 2019 to use Microsoft's AI algorithms on the enormous datasets used in pharma. The companies claimed that they intended to use picture analysis and generative techniques to create personalized medicine and enhance cell and gene therapy. In an effort to speed up and enhance the software's capacity to predict molecules, Nvidia, a maker of graphics processing units that has been stepping up its AI efforts, teamed up with Schrödinger in April.The market for AI in drug discovery is being strongly driven by the aforementioned factors.

Request For Free Sample:https://www.maximizemarketresearch.com/request-sample/161733

AI in Drug Discovery Market Report Scope and Research Methodology:

The bottom-up approach has been used to estimate the global and regional AI in Drug Discovery market size. Primary and secondary research methods have been used to gather the data for the AI in Drug Discovery market report. The report also includes a SWOT analysis and Porter’s five forces analysis, which helps to understand buyer-supplier relations and the strengths and weaknesses of the AI in Drug Discovery key competitors in the industry. The AI in Drug Discovery market report provides comprehensive coverage of import/export consumption, supply and demand, price, revenue generated, market share, market penetration, sales volume, and gross margins. The report also provides an in-depth analysis of each industry manufacturing site, capacity, production, market price, sales revenue, and market share.

AI in Drug Discovery Market Regional Analysis:

The report provides a comprehensive analysis of the AI in Drug Discovery market across all regions, including Europe, North America, Asia-Pacific, the Middle East and Africa, and Latin America. It examines the primary geographic conditions of the market, including all segments. The report also provides the current state of the regional AI in Drug Discovery market in terms of market size and share.

Request For Free Sample:https://www.maximizemarketresearch.com/request-sample/161733

AI in Drug Discovery Market Segmentation:

The AI in Drug Discovery Market is divided into Software and Services based on Offering. The services sector is predicted to have the largest CAGR between 2022 and 2029 and to hold the largest market share in the global AI in drug discovery services market in 2022. The benefits associated with AI services and the significant demand for AI services among end users are the primary factors driving the growth of this market segment.

AI in Drug Discovery Market Key Players:

1. GNS Healthcare (US)

2. BioSymetrics (US)

3. BPGbio, Inc (US)

4. Atomwise Inc (US)

5. Insitro (US)

6. NVIDIA Corporation (US)

7. IBM Corporation (US)

8. Microsoft Corporation (US)

9. Aria Pharmaceuticals, Inc. (US)

10. Insilico Medicine (US)

11. NuMedii, Inc. (US)

12. Owkin Inc. (US)

13. Schrödinger, Inc. (US)

14. DEEP GENOMICS (Canada)

15. Cyclica (Canada)

16. BenevolentAI (UK)

17. Exscientia (UK)

18. Iktos (France)

19. Euretos (Netherlands)

20. Evaxion Biotech A/S (Denmark)

21. XtalPi Inc (China)

22. Standigm (South Korea)

Request For Free Sample:https://www.maximizemarketresearch.com/request-sample/161733

Key Questions answered in the AI in Drug Discovery Market Report are:

What are the AI in Drug Discovery market segments?

What is the expected Market size by the end of the forecast period?

What is the expected CAGR of the AI in Drug Discovery market during the forecast period?

Which region held the largest market share in the AI in Drug Discovery Market?

What are the factors driving the AI in Drug Discovery Market?

What factors are affecting the AI in Drug Discovery market growth?

Who are the key players in the AI in Drug Discovery industry?

Key offerings:

Market Overview

Market Share

Market Size

Forecast |2023-2029

Market Dynamics- Growth drivers, Restraints, Investment Opportunities, and key trends

Market Segmentation- A detailed analysis of each segment and their segments

Competitive Landscape – Leading key players and other prominent key players.

Related Report:

Global Narrowband IoT (NBIoT) Chipset Market https://www.maximizemarketresearch.com/market-report/global-narrowband-iot-nb-iot-chipset-market/29666/

Pediatric Ultrasound Market https://www.maximizemarketresearch.com/market-report/global-pediatric-ultrasound-market/70033/

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

⮝ 444 West Lake Street, Floor 17,

Chicago, IL, 60606, USA.

✆ +1 800 507 4489

✆ +91 9607365656

? [email protected]

? www.maximizemarketresearch.com

Umesh kokane

The Role of Artificial Intelligence in Pharma: Revolutionizing Drug Discovery

apeksha motghare 2023-09-18

With the help of AI, the pharma industry is poised to revolutionize drug discovery, clinical trials, and patient care. Here are some of the ways in which pharma AI technology is being used:Drug Discovery:AI is being used to identify new drug targets, design new molecules, and predict drug efficacy and toxicity. While pharma AI technology has the potential to transform drug discovery, development, and patient care, there are also challenges associated with its use. Companies must ensure that patient data is stored securely and that AI algorithms are designed with data privacy and security in mind. Conclusion:Artificial Intelligence (AI) technology has the potential to transform the pharma industry by speeding up drug discovery, improving clinical trials, and providing personalized patient care.

Showcasing 12 Proven Use Cases of Generative AI in Healthcare

Daniel 1d

Transforming healthcare with AIFrom diagnosing diseases to predicting patient outcomes, AI has the capability to transform healthcare as we know it. Proven applications of Generative AIOne specific area of AI that has gained significant attention in healthcare is Generative AI. Let's explore 12 proven use cases of Generative AI in healthcare that have shown tremendous potential in advancing medical research, diagnosis, and treatment. Benefits of Generative AI in healthcareGenerative AI has the potential to revolutionize healthcare by improving patient outcomes, enabling personalized medicine, and optimizing healthcare delivery. In conclusion, the use cases of Generative AI in healthcare are vast and diverse.

AI for Drug Discovery Market Size, Status, Top Emerging Trends, Growth and Business Opportunities 2027

Fairfield Market Research 2022-06-08

While deepening AI penetration has been unlocking opportunities in disease diagnosis, and treatment, it has also been clearing its way in drug discovery. Fairfield Market Research intends to analyse the growth prospects of the application of AI for drug discovery and estimates the global revenue of the same to reach beyond US$1. While this reveals a drastically reduced time frame involved in the application of AI for drug discovery, there has been a constantly growing series funding in this market over the recent past. Venture capitalists are also stepping into the game, which is further uplifting the growth prospects of global market. Europe will follow with growing adoption of AI in healthcare and drug discovery.

AI in Healthcare: Revolutionizing Healthcare Policy is the New Norm

martechcube 2024-01-31

Similarly, in the healthcare industry, we can monitor our health and get personalized treatment with the help of artificial intelligence (AI), Natural language processing (NLP), and machine learning (ML) models and algorithms, which tech and healthcare visionaries refer to as AI in healthcare. Using modern-age technology, doctors, researchers, and other healthcare providers improve healthcare delivery in areas like preventive care, disease diagnosis and prediction, treatment plans, as well as care delivery and administrative work. Virtual CareThe shortage of medical professionals and personnel in critical healthcare areas has broadened the need to confront the challenge of delivering quality healthcare services. By using AI, healthcare sectors can increase patient retention rates and improve patients’ relationships with healthcare service providers. By automating these processes and implementing communication mechanisms, healthcare providers can improve the quality of services and reduce unnecessary waiting times for patients.

Jignesh Jariwala 2022-09-23

has added a new report titled, ‘Artificial Intelligence ( AI ) in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecasts, 2022 - 2027’ to its vast repository of research reports. The global Artificial Intelligence ( AI ) in Drug Discovery market was estimated at USD 0. Companies covered:Some of the key players in AI in Drug Discovery Market are Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrödinger (US), Atomwise, Inc. id=151193446The study categorizes the AI in drug discovery market into the following segments and subsegments:AI in drug discovery market, By Offering· Software· ServicesAI in drug discovery market, By Technology· Machine Learning· Deep Learning· Supervised Learning· Reinforcement Learning· Unsupervised Learning· Other Machine Learning Technologies· Other TechnologiesAI in drug discovery market, by Application· Immuno-oncology· Neurodegenerative diseases· Cardiovascular diseases· Metabolic diseases· Other ApplicationsAI in drug discovery market, By End User· Pharmaceutical & biotechnology companies· Contract research organizations· Research centers and academic & government institutesSome of the key geographies mentioned in this report include:· North America (U. S and Canada and rest of North America)· Europe (Germany, France, Italy, and Rest of Europe)· Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)· LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)Key questions answered in the report· What will be the market size and growth rate by the end of the forecast period?

Market Analysis and Industry report of Artificial Intelligence (AI) in Drug Discovery Market to 2028

irfan ahmad dar 2022-11-28

The ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY marketing report assists in determining and optimizing each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization. dbmr=global-artificial-intelligence-ai-in-drug-discovery-marketArtificial Intelligence (AI) in Drug Discovery Market Analysis and InsightsArtificial Intelligence (AI) is expected to be a lucrative technology in the healthcare industry. END USEPharmaceutical & Biotechnology CompaniesContract Research Organizations (CROs)Research Centres And Academic InstitutesOthersGlobal Artificial Intelligence (AI) in Drug Discovery Market Regional Analysis/InsightsThe countries covered in this market report are U. Global Artificial Intelligence (AI) in Drug Discovery Market Share AnalysisGlobal Artificial Intelligence (AI) in drug discovery market competitive landscape provides details by competitor. The above data points provided are only related to the company’s focus on the global Artificial Intelligence (AI) in drug discovery market.

WHO TO FOLLOW